Washington · Nonprofit
PATH DRUG SOLUTIONS
PATH DRUG SOLUTIONS (Washington) receives grants from 1 organization whose IRS filings report $15,000 to it, the largest being Silicon Valley Community Foundation ($15,000). 0 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2018
- $3.0M
- Funders on record
- 1
- Grants received
- $15k
- Net assets
- $0
What Path Drug Solutions does
Mission
The mission of Path Drug Solutions (pds) is to develop and advance safe and effective medicines for the prevention and treatment of diseases disproportionately affecting women and children in low-resource settings. We work with a variety of public- and private-sector stakeholders to build cross-sector collaborations, secure intellectual property, revisit promising drugs or drug candidates that have been set aside for nonmedical reasons (e.g., lack of earning potential), and harness scientific and manufacturing capacity in countries around the world to ensure that drugs are available, accessible, affordable, and acceptable and that supplies are sustainable to all those who need them.
As stated on its FY2018 Form 990.
Program
In november 2017, the pds board discussed dissolution pds. In 2018, a number of activities were carried out to complete the dissolution process, including product patent transfers from pds to path, engagement of legal counsel for dissolution procedures, and other administrative work. On december 31, 2018, the dissolution of pds was formally recognized by the california secretary of state.in january 2018, following the conclusion of the phase 2 clinical study of rilpivirine la, a long-acting injectable drug to prevent infection with hiv when used before exposure, pds completed all remaining study close-out activities. The investigational new drug application for rilpivirine la has been placed in an inactive status with the us food and drug administration, and the project is now finished.in 2018, pds continued work to reduce the burden of visceral leishmaniasis, also known as kala-azar. Kala-azar is a parasitic disease common in africa and asia and is almost always fatal if left untreated. Pds supported the government of nepal in active case detection using both a camp-based approach and an index case-based approach in kala-azar endemic districts. Pds also hosted an international…
The first program described on its most recent Form 990, which lists programs largest first by expense.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2017 to 2018, from $7.1M to $0 (−100%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 2 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
Grant support over time, funder by funder — shade shows the grant size each year.
1 of 1 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 100% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
Left out of every figure on this page: $193k from one payer (the payer shares this organization's board, largest Path). These are real filings, and they are not money PATH DRUG SOLUTIONS raised.
From the IRS filings of PATH DRUG SOLUTIONS’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
100% of PATH DRUG SOLUTIONS's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Too little is directly attributable to place on a map.
Funder states come from each funder’s own filing. $15k arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Organizations like PATH DRUG SOLUTIONS
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Washington
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
99% of spending goes to programs.
Governance
Footprint & structure
Files a return copy in 2 states
Part of a family of 3 related entities
- Path · exempt
- Path Vaccine Solutions · exempt
- Foundation for Appropriate Technologies in Health - Switzerland · exempt
Screen this organization
A dated, signed PDF of the compliance screen for PATH DRUG SOLUTIONS: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds PATH DRUG SOLUTIONS?
- PATH DRUG SOLUTIONS (Washington) receives grants from 1 organization whose IRS filings report $15,000 to it, the largest being Silicon Valley Community Foundation ($15,000). 0 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does PATH DRUG SOLUTIONS have?
- IRS filings report 1 organization giving $15,000 in grants to PATH DRUG SOLUTIONS.
- Who is the largest funder of PATH DRUG SOLUTIONS?
- Silicon Valley Community Foundation is the largest funder on record, with $15,000 in grants. The full list of funders is on this page.
- How can an organization like PATH DRUG SOLUTIONS find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Washington. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2018 (financials across 2017–2018), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing